A federal judge in Delaware tossed out a lawsuit by Roche company Genentech accusing Novartis’ Sandoz division of patent infringement. In this case, the patent was related to Genentech’s Esbriet (pirfenidone), which is used to treat idiopathic pulmonary fibrosis.

Illumina Inc. faces yet another setback from regulatory officials regarding the company’s $8 billion acquisition of GRAIL Inc. as the European Commission provided an update.

A Johnson & Johnson subsidiary proposed on February 18 that it would submit to an independent examination of the corporate restructuring the healthcare giant undertook in an attempt to settle in U.S. bankruptcy court thousands of lawsuits alleging that J&J baby powder and other talc products cause cancer.

The Sackler family owners of Purdue Pharma LP proposed a new and larger settlement worth up to $6 billion to resolve allegations that the OxyContin maker and the company’s owners contributed to the deadly U.S. opioid epidemic, a mediator’s report showed on February 18.

A federal judge on Feb. 1 extended a legal shield protecting the Sackler family owners of Purdue Pharma from lawsuits to Feb. 17, as they try to reach a deal with several states to settle sprawling litigation stemming from the U.S. opioid crisis.

An appeals court judge on Jan. 25 granted a stay in an appeal over mask mandates in New York, keeping the rule in effect during the legal process, New York Attorney General Letitia James said.

Novartis AG said on January 4 a U.S. court of appeals upheld the validity of a dosage regimen patent for the company’s multiple sclerosis treatment Gilenya, allowing a permanent injunction against Chinese generic drugmaker HEC Pharma to stay in place until the patent expires in 2027.

The Oklahoma Supreme Court overturned the landmark $465 million opioid verdict handed down against Johnson & Johnson in 2019.

U.S. Supreme Court Justice Stephen Breyer on Oct. 19 turned away a religious challenge to a requirement that healthcare workers in Maine be vaccinated against Covid-19, the latest such bid rejected by the nation’s top judicial body.

As the fraud trial of Theranos founder Elizabeth Holmes headlines the pharma legal news, other court-related cases are taking place, including a ruling in the legal spat between Takeda and AbbVie over a supply agreement for the prostate cancer drug Lupron.